Fresenius Medical Care stock moves against mixed return backdrop Fresenius Medical Care (XTRA:FME) has been drawing attention ...

Thank you, Dominik. Thank you for your continued interest in Fresenius Medical Care. On 30th of April, we successfully ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Add Yahoo as a preferred source to see more of our stories on Google. FRANKFURT (Reuters) - Investors demanded more clarity from German healthcare group Fresenius SE on Friday regarding its plans to ...

FME's Global Medical Office and Renal Research Institute (RRI) teams present multiple abstracts across a range of critical topics in nephrology, demonstrating how data, artificial intelligence, and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Fresenius Medical is the world's leading provider of products and services to treat kidney diseases. The company operates 4,060 dialysis clinics, serving roughly 343,000 patients across the world.

Shares in parent Fresenius drop to 2-year low FMC abandons 2025 targets CFO says some temp agencies lure nurses with $200/hour Medicare reimbursement increase may take 2 years July 28 (Reuters) - ...

Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over dialysis group Fresenius Medical Care AG (NYSE:FMS). The ...

FRANKFURT - Newly appointed Fresenius CEO Michael Sen said that the company's debt-financed growth strategy cannot continue, ...

Get all latest & breaking news on Fresenius Kabi. Watch videos, top stories and articles on Fresenius Kabi at moneycontrol.com.

(RTTNews) - Fresenius said that it plans to reduce its stake in Fresenius Medical Care AG from currently around 32.2% to no less than 25% plus one share. Fresenius intends to sell approximately 10.5 ...